The association between benzodiazepines and influenza‐like illness‐related pneumonia and mortality: a survival analysis using UK Primary Care data

  title={The association between benzodiazepines and influenza‐like illness‐related pneumonia and mortality: a survival analysis using UK Primary Care data},
  author={Georgina Nakafero and Robert D. Sanders and Jonathan S Nguyen-Van-Tam and Puja Myles},
  journal={Pharmacoepidemiology and Drug Safety},
  pages={1263 - 1273}
Bacterial superinfections, including pneumonia, are frequent complications of influenza‐like illness (ILI). Clinical and laboratory evidence suggests that benzodiazepines and Z‐drugs may influence susceptibility to infections and mortality. We investigated whether benzodiazepines and zopiclone modify the occurrence of ILI‐related pneumonia and mortality. 
Benzodiazepines or related drugs and risk of pneumonia: A systematic review and meta‐analysis
There are concerns that BZRDs increase the risk of pneumonia, so further research is needed to assess the potential risks and benefits of these drugs.
Prior benzodiazepine use and mortality among adult patients with sepsis: A retrospective population‐based cohort study in South Korea
Long-term benzodiazepine use is associated with increased 90-day mortality among adult patients with sepsis compared to non-users, and this association was more evident in benzidiazepine users with other psychiatric diseases, such as depression or anxiety disorder.
Pneumonia Risk Associated with the Use of Individual Benzodiazepines and Benzodiazepine Related Drugs among the Elderly with Parkinson’s Disease
Pneumonia risk varied based on their use of BZDs and BZRDs in older adult patients with PD, and zopiclone increased incident pneumonia risk.
Benzodiazepine Use and Risk of Community-Acquired Pneumonia in a Population-Based Cohort Study From North-Eastern Spain:
Background:Benzodiazepine (Bz) exposure has been identified as a risk factor of community-acquired pneumonia (CAP) in some observational studies, but this remains controversial. This study was
Benzodiazepines and Z-Drugs: An Updated Review of Major Adverse Outcomes Reported on in Epidemiologic Research
An overview and interpretation on the current state of evidence regarding each of benzodiazepine and Z-drug associations is provided and what gaps in the evidence for drug-exposure–harm associations need to be addressed in the future are proposed.
Benzodiazepines increase the likelihood of both infectious and thrombotic complications
Trauma patients with a positive UDS for BZDs had higher odds of both infectious and thrombotic complications, and odds of thromBotic complications were higher in those with infections.
History of Benzodiazepine Prescriptions and Risk of Dementia: Possible Bias Due to Prevalent Users and Covariate Measurement Timing in a Nested Case-Control Study
The findings overall are consistent with no causal effect of benzodiazepines or Z-drugs on dementia incidence.
Adverse effects of Z-drugs for sleep disturbance in people living with dementia: a population-based cohort study
Higher dose Z-drug use in dementia is associated with increased fracture and stroke risks, similar or greater to that for higher dose benzodiazepines, and non-pharmacological alternatives preferentially considered.


Association between benzodiazepine use and exacerbations and mortality in patients with asthma: a matched case‐control and survival analysis using the United Kingdom Clinical Practice Research Datalink
To investigate the association between the gamma‐aminobutyric acid (GABA)ergic drugs, benzodiazepines or zopiclone and the occurrence of asthma exacerbations and subsequent mortality in a cohort of
Use of Opioids or Benzodiazepines and Risk of Pneumonia in Older Adults: A Population‐Based Case–Control Study
To examine whether use of opioids or benzodiazepines is associated with risk of community‐acquired pneumonia in older adults, a large number of older adults were surveyed and the use of these drugs was found to be safe.
The impact of benzodiazepines on occurrence of pneumonia and mortality from pneumonia: a nested case-control and survival analysis in a population-based cohort
Benzodiazepines were associated with an increased risk of, and mortality from, CAP, and these hypothesis generating data suggest further research is required into the immune safety profile of benzodiazepine.
Effect of anxiolytic and hypnotic drug prescriptions on mortality hazards: retrospective cohort study
Objective To test the hypothesis that people taking anxiolytic and hypnotic drugs are at increased risk of premature mortality, using primary care prescription records and after adjusting for a wide
The use of benzodiazepines could be a protective factor for community-acquired pneumonia (CAP) in ≤60-year-old subjects
New data are presented from a previously published population-based case-control study carried out in a sample of 2662 subjects (1336 CAP patients and 1326 controls) to contribute to this unsolved question of the effect of BZs in patients with CAP.
Safety of benzodiazepines and opioids in very severe respiratory disease: national prospective study
Lower dose opioids are not associated with increased admissions or deaths in patients with COPD and might be safe for symptom reduction in severe respiratory disease.
Causes of death for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team cohort study.
Differences in the timing of death and risk factors for mortality suggest that future studies of community-acquired pneumonia should differentiate all-cause and pneumonia-related mortality.
Prognostic factors for serious morbidity and mortality from community-acquired lower respiratory tract infections among the elderly in primary care.
GPs need to be aware of readily available prognostic factors that can be used in primary care to complement physical examination and laboratory data in LRTI to guide preventive and therapeutic management decisions.
Bench-to-bedside review: Bacterial pneumonia with influenza - pathogenesis and clinical implications
The underlying mechanisms leading to combined viral/bacterial infection or post-influenza pneumonia are summarized and important considerations for effective treatment of bacterial pneumonia during and shortly after influenza are highlighted.
Effect of dexmedetomidine versus lorazepam on outcome in patients with sepsis: an a priori-designed analysis of the MENDS randomized controlled trial
In this a priori-determined subgroup analysis of septic vs non-septic patients from the MENDS double-blind randomized controlled trial, septic patients receiving dexmedetomidine had more days free of brain dysfunction and mechanical ventilation and were less likely to die than those that received a lorazepam-based sedation regimen.